Among the miRNAs differentially expressed on regorafenib treatment, four miRNAs (miR-494-3p, miR-3714, miR-4327, and miR-8073) were tumor suppressors associated with the decreased expression of cyclin D1 (Table 3). The gene discussed is CCND1; the disease is neoplasm.